We’ve Been Shortlisted in the 2021 SelectScience Scientists' Choice Awards®

Laboratory scientists across the globe are invited to vote for their favorite clinical products of 2020. Here’s how.
We’ve Been Shortlisted in the 2021 SelectScience Scientists' Choice Awards®

The 2021 Scientists Choice Awards®

SelectScience’s annual Scientists' Choice Awards is celebrating its 14th anniversary by honoring the most innovative and effective technologies of the past year. The awards provide scientists worldwide with the opportunity to acknowledge the instruments, assays, tools, or consumables that have made the most difference to their work.

Thanks to our loyal customers, we’re delighted to announce the Access SARS-CoV-2 IgM assay > has been nominated in the Best New Clinical Assay/Kit of 2020 category.

Our high-sensitivity and high-specificity SARS-CoV-2 IgM assay > has market-leading accuracy with a high positive predictive value (PPV) and a high negative predictive value (NPV). This provides clinicians with useful immune response information and may help determine if their patients have had a recent COVID-19 infection.

Casting Your Vote

Voting closes Sunday, June 13, 2021. All scientists who cast their vote for their favorite clinical products of 2020 will be entered into a drawing for a chance to win a $500/£400/450 € Amazon Gift Card from SelectScience.

Interested in sharing your thoughts?

Editorial Team
Editorial Team
The Beckman Coulter editorial team brings you timely news and resources focused on elevating clinical laboratory performance and advancing patient care.

Related Articles

A New Powerful Web Search Experience

A New Powerful Web Search Experience

Beckman Coulter is thrilled to introduce a revolutionary new web search experience, empowering you to find information faster, making your searches more productive than ever before.
Bacterial Resistance: Actions from the Core Microbiology Lab

Bacterial Resistance: Actions from the Core Microbiology Lab

Learn from our MicroTeam some “MicroTips” about the critical role of the microbiology laboratory for patients, reporting, and the larger impact to antimicrobial stewardship.
Alzheimer’s disease: Challenges to diagnosis and the emerging treatment landscape

Alzheimer’s disease: Challenges to diagnosis and the emerging treatment landscape

Alzheimer's disease is the most common form of dementia. The prevalence of this debilitating disease is expected to continue to rise in the coming years as the global population ages, making it an increasingly important global public health issue.